Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment [Phase 3]

View source ↗

Summary

This is a Phase 3 trial evaluating the efficacy, safety, and tolerability of canagliflozin in adults with type 2 diabetes mellitus and moderate renal impairment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2, Renal Insufficiency | Phase 3 | Status: COMPLETED | Results posted: 2013-05-27